Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Figitumumab in refractory metastatic colorectal cancer
NCT00560560Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of figitumumab in colorectal cancer (CRC), sponsored by Pfizer. Started Dec 2007; status: completed.
02
Drugs
figitumumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00560560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560560.